Jerrell Shelton Sells 2,894 Shares of CryoPort (NASDAQ:CYRX) Stock

CryoPort, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton sold 2,894 shares of CryoPort stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $8.18, for a total value of $23,672.92. Following the completion of the sale, the chief executive officer owned 1,051,607 shares of the company’s stock, valued at $8,602,145.26. The trade was a 0.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Jerrell Shelton also recently made the following trade(s):

• On Monday, March 16th, Jerrell Shelton sold 7,918 shares of CryoPort stock. The stock was sold at an average price of $8.00, for a total transaction of $63,344.00.

CryoPort Stock Performance

CryoPort stock traded up $0.26 during midday trading on Wednesday, hitting $8.41. 325,336 shares of the company’s stock were exchanged, compared to its average volume of 480,669. The company has a market cap of $419.32 million, a PE ratio of 6.37 and a beta of 1.69. The firm has a 50-day moving average of $8.90 and a two-hundred day moving average of $9.32. CryoPort, Inc. has a 12 month low of $4.63 and a 12 month high of $11.45.

CryoPort (NASDAQ:CYRX) last posted its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.02). CryoPort had a net margin of 42.35% and a negative return on equity of 8.22%. The business had revenue of $45.45 million during the quarter, compared to the consensus estimate of $42.92 million. As a group, equities analysts expect that CryoPort, Inc. will post -0.99 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Mak Capital One LLC acquired a new position in shares of CryoPort during the third quarter worth $7,756,000. UBS Group AG boosted its position in shares of CryoPort by 112.7% in the 3rd quarter. UBS Group AG now owns 1,331,521 shares of the company’s stock worth $12,623,000 after purchasing an additional 705,649 shares in the last quarter. Millennium Management LLC grew its stake in CryoPort by 23.8% during the 4th quarter. Millennium Management LLC now owns 3,244,802 shares of the company’s stock worth $31,150,000 after buying an additional 623,896 shares during the last quarter. Kennedy Capital Management LLC purchased a new position in CryoPort during the 2nd quarter worth $4,084,000. Finally, Assenagon Asset Management S.A. increased its position in CryoPort by 37.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company’s stock valued at $14,208,000 after buying an additional 408,263 shares in the last quarter. Hedge funds and other institutional investors own 92.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Weiss Ratings restated a “sell (d+)” rating on shares of CryoPort in a report on Monday, December 29th. Needham & Company LLC lifted their price target on CryoPort from $12.00 to $13.00 and gave the company a “buy” rating in a report on Wednesday, March 4th. Finally, Wall Street Zen cut CryoPort from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Eight analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, CryoPort presently has an average rating of “Moderate Buy” and a consensus target price of $12.94.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.